Drug Profile
Follitropin beta biosimilar - Reliance Life Sciences
Alternative Names: FostiRelLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Reliance Life Sciences
- Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins
- Mechanism of Action Gonadal steroid hormone stimulants; Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Female infertility; Sex hormone disorders
Most Recent Events
- 26 Oct 2012 Launched for Female infertility in India (SC) before October 2012
- 26 Oct 2012 Launched for Sex hormone disorders (spermatogenesis in males) in India (SC) before October 2012